Patents by Inventor Marion Wienrich

Marion Wienrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210205324
    Abstract: The invention relates to methods for preventing, slowing the progression of, delaying or treating metabolic disorders induced in patients by the treatment with neuroleptic agents comprising administering to the patients an SGLT2 inhibitor.
    Type: Application
    Filed: October 19, 2020
    Publication date: July 8, 2021
    Inventors: Marion WIENRICH, Eric Williams MAYOUX
  • Publication number: 20200222423
    Abstract: The invention relates to methods for preventing, slowing the progression of, delaying or treating metabolic disorders induced in patients by the treatment with neuroleptic agents comprising administering to the patients an SGLT2 inhibitor.
    Type: Application
    Filed: October 21, 2019
    Publication date: July 16, 2020
    Inventors: Marion WIENRICH, Eric Williams MAYOUX
  • Publication number: 20180177794
    Abstract: The invention relates to methods for preventing, slowing the progression of, delaying or treating metabolic disorders induced in patients by the treatment with neuroleptic agents comprising administering to the patients an SGLT2 inhibitor.
    Type: Application
    Filed: February 22, 2018
    Publication date: June 28, 2018
    Inventors: Marion WIENRICH, Eric Williams MAYOUX
  • Publication number: 20160074415
    Abstract: The invention relates to methods for preventing, slowing the progression of, delaying or treating metabolic disorders induced in patients by the treatment with neuroleptic agents comprising administering to the patients an SGLT2 inhibitor.
    Type: Application
    Filed: November 24, 2015
    Publication date: March 17, 2016
    Inventors: Marion WIENRICH, Eric Williams MAYOUX
  • Publication number: 20130137646
    Abstract: The invention relates to methods for preventing, slowing the progression of, delaying or treating metabolic disorders induced in patients by the treatment with neuroleptic agents comprising administering to the patients an SGLT2 inhibitor.
    Type: Application
    Filed: May 31, 2012
    Publication date: May 30, 2013
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Marion WIENRICH, Eric Williams Mayoux
  • Publication number: 20100081625
    Abstract: The present invention relates to a method for treating, preventing or slowing, delaying or reversing progression of one or more neurodegenerative disorders in a patient in need thereof characterized by administering a glucopyranosyl-substituted benzene derivative, a tautomer, stereoisomer, mixture or salt thereof, as defined in claim 1 to the patient in need thereof.
    Type: Application
    Filed: January 25, 2008
    Publication date: April 1, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Marion Wienrich, Juergen Reess
  • Publication number: 20090012161
    Abstract: This invention describes a new combination for the treatment of bladder function disorders which comprises a serotonin- and/or norepinephrine-reuptake inhibitor and a beta-3-adrenoceptor agonist.
    Type: Application
    Filed: May 24, 2005
    Publication date: January 8, 2009
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Ludwig Mehlburger, Martin Michel, Marion Wienrich, Ursula Ebinger
  • Publication number: 20070129435
    Abstract: This invention describes the use of beta-3-adrenoceptor agonists for the treatment of functional bladder disorders, particularly stress incontinence and/or mixed incontinence.
    Type: Application
    Filed: February 7, 2007
    Publication date: June 7, 2007
    Inventors: Martin Michel, Marion Wienrich, Ursula Ebinger
  • Publication number: 20060004105
    Abstract: This invention describes the use of beta-3-adrenoceptor agonists for the treatment of functional bladder disorders, particularly stress incontinence and/or mixed incontinence.
    Type: Application
    Filed: October 29, 2004
    Publication date: January 5, 2006
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Martin Michel, Marion Wienrich, Ursula Ebinger
  • Publication number: 20050261369
    Abstract: This invention describes a new combination for the treatment of bladder function disorders which comprises a serotonin- and/or norepinephrine-reuptake inhibitor and a beta-3-adrenoceptor agonist.
    Type: Application
    Filed: May 24, 2005
    Publication date: November 24, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Ludwig Mehlburger, Martin Michel, Marion Wienrich, Ursula Ebinger
  • Publication number: 20050261328
    Abstract: A pharmaceutical composition useful in the treatment of functional bladder disorders comprising an antimuscarinic agent and a beta-3-adrenoceptor agonist is described.
    Type: Application
    Filed: May 24, 2005
    Publication date: November 24, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Marion Wienrich, Martin Michel, Ludwig Mehlburger, Ursula Ebinger
  • Publication number: 20050154041
    Abstract: This invention describes a new combination for the treatment of functional bladder disorders which comprises alpha agonists and a beta-3-adrenoceptor agonist.
    Type: Application
    Filed: November 4, 2004
    Publication date: July 14, 2005
    Applicant: Boehringer Ingelhein International GmbH
    Inventors: Martin Michel, Ursula Ebinger, Marion Wienrich
  • Publication number: 20050119239
    Abstract: This invention describes a new combination for the treatment of functional bladder disorders which comprises a beta-3-adrenoceptor agonist and an active substance which influences prostaglandin metabolism.
    Type: Application
    Filed: November 17, 2004
    Publication date: June 2, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Marion Wienrich, Antje Howitz
  • Publication number: 20050101607
    Abstract: This invention describes a new combination for the treatment of functional bladder disorders which comprises an alpha antagonist and/or 5-alpha-reductase inhibitor and a beta-3-adrenoceptor agonist.
    Type: Application
    Filed: November 3, 2004
    Publication date: May 12, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Martin Michel, Ursula Ebinger, Marion Wienrich
  • Publication number: 20040266794
    Abstract: The invention relates to the use of dopamine receptor agonists for preparing a pharmaceutical composition for reducing excessive food intake.
    Type: Application
    Filed: March 16, 2004
    Publication date: December 30, 2004
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Joachim Mierau, Juergen Reess, Marion Wienrich
  • Patent number: 6573276
    Abstract: Methods of lowering the levels of A&bgr;40, A&bgr;42 and tau protein in a mammal comprising administering to the mammal an effective amount of talsaclidine, or a physiologically acceptable acid addition salt thereof, and methods of treating diseases associated with the formation of diffuse and senile plaques or A&bgr;40-, A&bgr;42- and tau-containing plaques are disclosed.
    Type: Grant
    Filed: April 30, 2002
    Date of Patent: June 3, 2003
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Christoph Hock, Andreas Raschig, Marion Wienrich, Roger Nitsch, Klaus Mendla, Dieter Horst Meier, Klaus Bornemann, Cornelia Dorner-Ciossek
  • Publication number: 20030050221
    Abstract: A method of lowering the levels of A&bgr;40, A&bgr;42, and tau protein in a mammal comprising administering to the mammal an effective amount of talsaclidine or a physiologically acceptable acid addition salt thereof and methods of treating or preventing diseases associated with the formation of diffuse and senile plaques or A&bgr;40-, A&bgr;42- and tau-containing plaques.
    Type: Application
    Filed: April 30, 2002
    Publication date: March 13, 2003
    Inventors: Christoph Hock, Andreas Raschig, Marion Wienrich, Roger Nitsch, Klaus Mendla, Dieter Horst Meier, Klaus Bornemann, Cornelia Dorner-Ciossek
  • Patent number: 6492407
    Abstract: A method for treating a neurodegenerative disease or cerebral ischemia arising from conditions selected from the group consisting of Status epilepticus, hypoglycaemia, hypoxia, anoxia, brain trauma, brain oedema, amyotropic lateral sclerosis, Huntington's disease, Alzheimer's disease, hypotonia, cardiac infarction, brain pressure (elevated intracranial pressure), ischaemic and haemorrhagic stroke, global cerebral ischaemia with heart stoppage, diabetic polyneuropathy, tinnitus, perinatal asphyxia, psychosis, schizophrenia, depression, and Parkinson's disease, the method of treatment comprising administering to a host in need of such treatment a therapeutic amount of a compound of formula (I) wherein R1, R2, R3, R4, R5, R6, and R7 are as defined herein, or a pharmaceutically acceptable salt thereof, and pharmaceutical compositions containing a compound of formula (I).
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: December 10, 2002
    Assignee: Boehringer Imgelheim Pharma KG
    Inventors: Michael Brenner, Wolf-Dietrich Bechtel, Rainer Palluk, Marion Wienrich, Thomas Weiser
  • Publication number: 20020045651
    Abstract: A method for treating a neurodegenerative disease or cerebral ischemia arising from conditions selected from the group consisting of Status epilepticus, hypoglycaemia, hypoxia, anoxia, brain trauma, brain oedema, amyotropic lateral sclerosis, Huntington's disease, Alzheimer's disease, hypotonia, cardiac infarction, brain pressure (elevated intracranial pressure), ischaemic and haemorrhagic stroke, global cerebral ischaemia with heart stoppage, diabetic polyneuropathy, tinnitus, perinatal asphyxia, psychosis, schizophrenia, depression, and Parkinson's disease, the method of treatment comprising administering to a host in need of such treatment a therapeutic amount of a compound of formula (I) 1
    Type: Application
    Filed: April 23, 2001
    Publication date: April 18, 2002
    Inventors: Michael Brenner, Wolf-Dietrich Bechtel, Rainer Palluk, Marion Wienrich, Thomas Weiser
  • Patent number: 6277872
    Abstract: The invention relates to oxadiazole derivatives of general formula (I) wherein X, Y, Z and R1 are defined as described in the specification and claims, processes for preparing them and their use as pharmaceutical compositions.
    Type: Grant
    Filed: July 26, 1999
    Date of Patent: August 21, 2001
    Assignee: Boehringer Ingelheim KG
    Inventors: Michael Brenner, Roland Maier, Marion Wienrich, Thomas Weiser, Rainer Palluk, Wolf-Dietrich Bechtel, Angelo Sagrada, Helmut Ensinger, Uwe Pschorn, Raffaele Cesana